明達醫 (6527) 月營收分析比較圖

明達醫 (6527) 月營收報表

年度/月份	營業收入（單位：千元）				累計營業收入（單位：千元）
年度/月份	單月營收	去年同月營收	單月月增率	單月年增率	累計營收	去年累計營收	累積年增率
2024/03	65,681	86,516	-3.4%	-24.1%	199,451	207,831	-4%
2024/02	67,976	73,429	3.3%	-7.4%	133,770	121,315	10.3%
2024/01	65,794	47,886	-0.6%	37.4%	65,794	47,886	37.4%
2023/12	66,220	72,045	7.7%	-8.1%	823,964	795,455	3.6%
2023/11	61,465	73,586	-0.5%	-16.5%	757,744	723,410	4.7%
2023/10	61,763	86,015	-11.3%	-28.2%	696,279	649,824	7.1%
2023/09	69,618	67,392	-3.9%	3.3%	634,274	563,809	12.5%
2023/08	72,479	69,040	-6.6%	5%	564,656	496,417	13.7%
2023/07	77,615	73,230	-6.5%	6%	492,177	427,377	15.2%
2023/06	83,038	82,562	21.2%	0.6%	414,562	354,147	17%
2023/05	68,516	59,485	24.2%	15.2%	331,524	271,585	22.1%
2023/04	55,177	74,467	-36.2%	-25.9%	263,008	212,100	24%
2023/03	86,516	51,913	17.8%	66.7%	207,831	137,633	51%
2023/02	73,429	42,569	53.3%	72.5%	121,315	85,720	41.5%
2023/01	47,886	43,151	-33.5%	11%	47,886	43,151	11%
2022/12	72,045	57,165	-2.1%	26%	795,455	721,613	10.2%
2022/11	73,586	73,762	-14.4%	-0.2%	723,410	664,448	8.9%
2022/10	86,015	62,355	27.6%	37.9%	649,824	590,686	10%
2022/09	67,392	62,372	-2.4%	8%	563,809	528,331	6.7%
2022/08	69,040	66,986	-5.7%	3.1%	496,417	465,959	6.5%
2022/07	73,230	50,729	-11.3%	44.3%	427,377	398,973	7.1%
2022/06	82,562	50,431	38.8%	63.7%	354,147	348,244	1.7%
2022/05	59,485	58,351	-20.1%	1.9%	271,585	297,813	-8.8%
2022/04	74,467	61,898	43.4%	20.3%	212,100	239,462	-11.4%
2022/03	51,913	70,138	22%	-26%	137,633	177,564	-22.5%
2022/02	42,569	50,529	-1.3%	-15.8%	85,720	107,426	-20.2%
2022/01	43,151	56,897	-24.5%	-24.1%	43,151	56,897	-24.1%
2021/12	57,165	57,088	-22.5%	0.1%	721,613	504,370	43.1%
2021/11	73,762	64,133	18.3%	15%	664,448	447,282	48.5%
2021/10	62,355	51,910	0%	20.1%	590,686	383,149	54.2%
2021/09	62,372	53,277	-6.9%	17.1%	528,331	331,239	59.5%
2021/08	66,986	59,920	32%	11.8%	465,959	277,962	67.6%
2021/07	50,729	40,830	0.6%	24.2%	398,973	218,042	83%
2021/06	50,431	26,727	-13.6%	88.7%	348,244	177,212	96.5%
2021/05	58,351	19,781	-5.7%	195%	297,813	150,485	97.9%
2021/04	61,898	16,643	-11.7%	271.9%	239,462	130,704	83.2%